Replimune Group, Inc (REPL) Stock Price

21.02 ▲ +0.39 (+1.89%)
Open: 20.59 Vol: 30.58K Day's range: 20.05 - 21.64 May 22, 16:00 EDT
IEX Real-Time Price
Free Stock Screener
Loading chart ...
REPL Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 21.04▼ 21.09▼ 20.99▼ 20.66▲ 17.60▲
MA10 21.07▼ 20.97▼ 20.83▼ 19.88▲ 14.21▲
MA20 21.05▼ 20.90▼ 20.68▲ 18.17▲ 15.08▲
MA50 20.85▼ 20.81▲ 20.10▲ 13.70▲ 14.11▲
MA100 20.92▼ 19.72▲ 19.04▲ 14.92▲ N/A    
MA200 19.82▲ 17.26▲ 15.22▲ 14.18▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.028▼ -0.010▼ -0.028▼ 0.111▲ N/A    
RSI 47.347▼ 49.703▼ 52.076▲ 65.753▲ N/A    
STOCH 51.747     72.753     54.403     70.524     67.629    
WILL %R -47.782     -47.782     -47.782     -18.287▲ -8.192▲
CCI -40.125     -25.404     11.050     105.717▲ 144.161▲
Latest Filters Detected On REPL
MA $REPL Price Crossed Above MA(7) Set Alert
MA $REPL Price Crossed Above MA(13) Set Alert
▲ MACD $REPL MACD(12,26,9) Crossed Above Signal Line Set Alert
▲ RSI&MACD $REPL MACD cross and RSI above 55 Set Alert
Replimune Group, Inc News
The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering
Tuesday, May 19, 2020 09:07 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Down In The Dumps (Biotech Stocks Hitting 52-week ...
The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering
Tuesday, May 19, 2020 05:59 AM
Here's a roundup of top developments in the biotech space over the last 24 hours: (Biotech Stocks Hitting 52-week Highs May 18) Load Error (Biotech Stocks Hitting 52 ...
Top Analyst Upgrades and Downgrades: AppFolio, BioCryst, Booking, DraftKings, Intuit, L Brands, Peloton, Salesforce, Wells Fargo and More
Tuesday, May 05, 2020 06:32 AM
The consensus price target was $38.48. Replimune Group Inc. (NASDAQ: REPL) was started with an Overweight rating and a $21 price target (versus a $15.93 close) at Barclays. Salesforce.com Inc ...
REPL historical stock data
date open high low close volume
22/05/20 20.59 21.64 20.05 21.02 30,577
21/05/20 20.57 21.295 20.46 20.63 32,294
20/05/20 20.00 20.79 19.345 20.71 68,977
19/05/20 21.01 21.15 19.50 19.72 64,657
18/05/20 20.96 22.13 20.15 21.22 136,144
15/05/20 19.26 20.33 18.20 20.27 68,416
14/05/20 18.69 19.40 17.765 19.30 59,181
13/05/20 18.12 19.31 18.12 19.20 70,429
12/05/20 18.22 19.60 17.51 18.39 94,341
11/05/20 18.64 19.20 18.1799 18.32 70,092
Quote Details
52wk Low:8.58
52wk High:22.13
Vol:30.58K
Avg Vol(3m):1.8M
1Y Chng:+64.35%
1M Chng:+91.26%
Add to Watch List
More Information
Index NASDAQ Composite
Market Cap. 770.29M